Science Business: The Promise, the Reality, and the Future of Biotech

3.67 avg rating
( 72 ratings by Goodreads )
 
9781591398400: Science Business: The Promise, the Reality, and the Future of Biotech
View all copies of this ISBN edition:
 
 

Why has the biotechnology industry failed to perform up to expectations—despite all its promise? In Science Business, Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter—term 'monetisation' of intellectual property. Pisano maintains that all industry players—biotech firms, investors, universities, pharmaceutical companies, government regulators—can play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being.

"synopsis" may belong to another edition of this title.

From the Back Cover:

"A very insightful analysis of the remarkable evolution of the biotech industry. This is required reading for all involved in this process, biotechnology entrepreneurs, venture capitalists, academics, research centers, policy makers and investors.

- Henri Termeer, Chairman, President and CEO, Genzyme Corporation

“In this startling and cogent diagnosis of, and prognosis for, the biotechnology industry, Gary Pisano weaves a powerful economic argument that all is not well in biotechnology, an industry that should be the best hope for a better healthcare for us all. We in the industry need better to grapple with the challenges posed by this provocative book."

- Dr. Josh Boger, President and CEO of Vertex Pharmaceuticals

“The industrial structure that has arisen in the United States to develop and exploit the potential of biotechnology is widely regarded as extremely effective. But is it? Few biotech firms have made a profit, and the rate of introduction of new effective pharmaceuticals is not impressive. Gary Pisano’s fine study is the first to bring these ideas into the open, analyze them, and reflect on what they might mean for the future of biotechnology.”

- Richard Nelson, George Blumenthal Professor of International and Public Affairs, Business and Law, Emeritus, Columbia University

“Gary Pisano's analysis uncovers surprising facts about the industry's innovation power and productivity, challenging conventional wisdom. Science Business is refreshing and inspiring for anyone who is interested in the future success of biotechnology, including life science executives, investors, policy-makers and, most importantly, the patients who it has the potential to help the most"

- Dr. Daniel Vasella, Chairman & CEO, Novartis AG

About the Author:

Gary P. Pisano is the Harry E. Figgle Jr. Professor of Business Administration and Head of the Technology and Operations Management unit at Harvard Business School.

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Pisano, Gary P.
Published by Harvard Business School Press
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Hardcover Quantity Available: 1
Seller:
WCC Corp.
(Moorpark, CA, U.S.A.)
Rating
[?]

Book Description Harvard Business School Press. Hardcover. Condition: New. 1591398401 New book in dust jacket. Seller Inventory # G5-636

More information about this seller | Contact this seller

Buy New
US$ 15.11
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

2.

Pisano, Gary P.
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Quantity Available: > 20
Seller:
INDOO
(Avenel, NJ, U.S.A.)
Rating
[?]

Book Description Condition: New. Brand New. Seller Inventory # 1591398401

More information about this seller | Contact this seller

Buy New
US$ 20.43
Convert currency

Add to Basket

Shipping: US$ 3.60
Within U.S.A.
Destination, rates & speeds

3.

Pisano, Gary P.
Published by Harvard Business School Press (2006)
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Hardcover Quantity Available: 1
Seller:
Murray Media
(NORTH MIAMI BEACH, FL, U.S.A.)
Rating
[?]

Book Description Harvard Business School Press, 2006. Hardcover. Condition: New. Never used!. Seller Inventory # 1591398401

More information about this seller | Contact this seller

Buy New
US$ 27.32
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds

4.

Gary P. Pisano
Published by Harvard Business School Press (2006)
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Hardcover Quantity Available: 1
Seller:
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Harvard Business School Press, 2006. Hardcover. Condition: New. 1. Seller Inventory # DADAX1591398401

More information about this seller | Contact this seller

Buy New
US$ 24.44
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

5.

Gary P. Pisano
Published by Harvard Business School Press (2006)
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Portland, ME, U.S.A.)
Rating
[?]

Book Description Harvard Business School Press, 2006. Condition: New. book. Seller Inventory # M1591398401

More information about this seller | Contact this seller

Buy New
US$ 27.68
Convert currency

Add to Basket

Shipping: US$ 3.27
Within U.S.A.
Destination, rates & speeds

6.

Gary P. Pisano
Published by Harvard Business School Press (2006)
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Portland, ME, U.S.A.)
Rating
[?]

Book Description Harvard Business School Press, 2006. Condition: New. book. Seller Inventory # MB00P8ZG6DM

More information about this seller | Contact this seller

Buy New
US$ 27.68
Convert currency

Add to Basket

Shipping: US$ 3.27
Within U.S.A.
Destination, rates & speeds

7.

Gary P. Pisano
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Hardcover First Edition Quantity Available: 1
Seller:
Grand Eagle Retail
(Wilmington, DE, U.S.A.)
Rating
[?]

Book Description Hardcover. Condition: New. 1st. Hardcover. Why has the biotechnology industry failed to perform up to expectations - despite all its promise? In Science Business, Gary P. Pisano answers this question by providing an incisive critiq.Shipping may be from multiple locations in the US or from the UK, depending on stock availability. 237 pages. 0.531. Seller Inventory # 9781591398400

More information about this seller | Contact this seller

Buy New
US$ 31.24
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds

8.

Gary P. Pisano
Published by Harvard Business School Press
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Hardcover Quantity Available: 2
Seller:
BuySomeBooks
(Las Vegas, NV, U.S.A.)
Rating
[?]

Book Description Harvard Business School Press. Hardcover. Condition: New. 256 pages. Dimensions: 9.2in. x 6.5in. x 0.9in.Why has the biotechnology industry failed to perform up to expectationsdespite all its promise In Science Business, Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotechs problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industrys performance. According to Pisano, the biotech industrys problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R and D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases. The key to fixing the industry Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorterterm monetisation of intellectual property. Pisano maintains that all industry playersbiotech firms, investors, universities, pharmaceutical companies, government regulatorscan play a role in righting the industry. The payoff Valuable improvements in health care, and a shinier future for human well-being. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Hardcover. Seller Inventory # 9781591398400

More information about this seller | Contact this seller

Buy New
US$ 31.96
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds

9.

Gary P. Pisano
Published by Harvard Business Review Press, United States (2006)
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Hardcover Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Harvard Business Review Press, United States, 2006. Hardback. Condition: New. Language: English. Brand new Book. Why has the biotechnology industry failed to perform up to expectations--despite all its promise? In Science Business, Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter--term 'monetisation' of intellectual property.Pisano maintains that all industry players--biotech firms, investors, universities, pharmaceutical companies, government regulators--can play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being. Seller Inventory # BTE9781591398400

More information about this seller | Contact this seller

Buy New
US$ 35.01
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

10.

Pisano, Gary P.
Published by Harvard Business School Press
ISBN 10: 1591398401 ISBN 13: 9781591398400
New Hardcover Quantity Available: 2
Seller:
Russell Books
(Victoria, BC, Canada)
Rating
[?]

Book Description Harvard Business School Press. Hardcover. Condition: New. 1591398401 Special order direct from the distributor. Seller Inventory # ING9781591398400

More information about this seller | Contact this seller

Buy New
US$ 35.00
Convert currency

Add to Basket

Shipping: US$ 7.00
From Canada to U.S.A.
Destination, rates & speeds

There are more copies of this book

View all search results for this book